Croda welcomes Thomas Riermeier as new President of Life Sciences

PRESS RELEASE

1 April 2025: Croda International Plc, the company that uses smart science to create ingredients and technologies that improve lives, today announces that Dr. Thomas Riermeier has been appointed as the new President, Life Sciences and will also be joining the Croda Executive Committee. The role covers Croda’s Pharma and Agricultural businesses and is effective from 1 April, 2025. 

Thomas is a seasoned professional with extensive global leadership experience in the pharmaceutical and chemical industries. From March 2020 to June 2024, he was Senior Vice President and General Manager of Evonik’s Health Care business line, overseeing a global organisation with ten production sites and a global network of applications service laboratories. His responsibilities included the business of pharmaceutical excipients, advanced drug delivery technologies, including drug products and active pharmaceutical ingredients. He holds a PhD in Chemistry from the Technical University of Munich and an MBA from Aston University.

Commenting, Steve Foots, Group Chief Executive Officer, said "I am thrilled to welcome Thomas to Croda. His wealth of experience and proven strategic leadership skills make him a valuable addition to the team. I look forward to working with him as we drive growth and innovation forward across Life Sciences.”

Thomas commented, “I am delighted to be joining Croda, particularly in this milestone centenary year. From agriculture and food security to pharmaceuticals and healthcare, Croda’s purpose, Smart science to improve lives™, aligns perfectly with my passion for innovation and sustainability. After a fantastic first week, where I had the opportunity to engage with teams across the organisation, I see immense potential in driving innovation, and I am eager to collaborate with our teams, partners and customers to drive meaningful impact across our pharmaceutical and agricultural markets."